Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials

被引：0
|
作者：
Thomas G. Nührenberg
Willibald Hochholzer
Kambis Mashayekhi
Miroslaw Ferenc
Franz-Josef Neumann
机构：
[1] University Heart Center Freiburg—Bad Krozingen,Department of Cardiology and Angiology II
来源：
Clinical Research in Cardiology | 2018年 / 107卷
关键词：
Acute coronary syndrome; Percutaneous coronary intervention; Bivalirudin; Heparin; Glycoprotein inhibitors; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：807 / 815
页数：8
相关论文
共 50 条
  • [1] Efficacy and safety of bivalirudin for percutaneous coronary intervention in acute coronary syndromes: a meta-analysis of randomized-controlled trials
    Nuehrenberg, Thomas G.
    Hochholzer, Willibald
    Mashayekhi, Kambis
    Ferenc, Miroslaw
    Neumann, Franz-Josef
    [J]. CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (09) : 807 - 815
  • [2] Bivalirudin therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials
    Pizzi, C.
    Costa, G. M.
    Manzoli, L.
    Bugiardini, R.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 991 - 991
  • [3] Efficacy and safety of bivalirudin versus heparin in patients undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials
    Zhang, Shuo
    Gao, Weihua
    Li, Haixia
    Zou, Meijuan
    Sun, Sihao
    Ba, Yijie
    Liu, Yang
    Cheng, Gang
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 209 : 87 - 95
  • [4] Efficacy and safety of bivalirudin vs heparin in patients with coronary heart disease undergoing percutaneous coronary intervention A meta-analysis of randomized controlled trials
    Liu, Xiao-Qiang
    Luo, Xian-Du
    Wu, Yan-Qing
    [J]. MEDICINE, 2020, 99 (06)
  • [5] Bivalirudin versus Heparin for Percutaneous Coronary Intervention: An Updated Meta-Analysis of Randomized Controlled Trials
    Lipinski, Michael J.
    Lhermusier, Thibault
    Escarcega, Ricardo O.
    Baker, Nevin C.
    Magalhaes, Marco A.
    Torguson, Rebecca
    Suddath, William O.
    Satler, Lowell F.
    Pichard, Augusto
    Waksman, Ron
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B137 - B137
  • [6] Bivalirudin versus heparin for percutaneous coronary intervention: an updated meta-analysis of randomized controlled trials
    Lipinski, Michael J.
    Lhermusier, Thibault
    Escarcega, Ricardo O.
    Baker, Nevin C.
    Magalhaes, Marco A.
    Torguson, Rebecca
    Suddath, William O.
    Satler, Lowell F.
    Pichard, Augusto D.
    Waksman, Ron
    [J]. CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2014, 15 (6-7) : 315 - 322
  • [7] Efficacy and safety of bivalirudin versus heparin in patients with diabetes mellitus undergoing percutaneous coronary intervention A meta-analysis of randomized controlled trials
    Zhang, Juan
    Yang, Xinchun
    [J]. MEDICINE, 2017, 96 (29)
  • [8] Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials
    Valgimigli, Marco
    Biondi-Zoccai, Giuseppe
    Tebaldi, Matteo
    van't Hof, Arnoud W. J.
    Campo, Gianluca
    Hamm, Christian
    ten Berg, Jurrien
    Bolognese, Leonardo
    Saia, Francesco
    Danzi, Gian Battista
    Briguori, Carlo
    Okmen, Ertan
    King, Spencer B.
    Moliterno, David J.
    Topol, Eric J.
    [J]. EUROPEAN HEART JOURNAL, 2010, 31 (01) : 35 - 49
  • [9] Bivalirudin versus heparin during percutaneous coronary intervention: a meta-analysis of randomized trials
    Cassese, Salvatore
    Byrne, Robert
    Schunkert, Heribert
    Berger, Peter B.
    Kastrati, Adnan
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [10] Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes
    Bates E.R.
    [J]. Current Cardiology Reports, 2001, 3 (5) : 348 - 354
12345